QQ客服 官方微博 反馈留言

	Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.
	Xu, Shan; Zhou, Yanping; Geng, Hui; Song, Dandan; Tang, Jing; Zhu, Xianmin; Yu, Di; Hu, Sheng*; Cui, Yanfang*
刊名	SCIENTIFIC REPORTS
	2017
卷号	7期号:1页码:17524
ISSN号	2045-2322
DOI	10.1038/s41598-017-16085-y
URL标识	查看原文
WOS记录号	WOS:000417796000044
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5159245
专题	华中师范大学
作者单位	1.[Zhou, Yanping 2.Song, Dandan 3.Cui, Yanfang 4.Xu, Shan] Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Hubei, Peoples R China.
推荐引用方式 GB/T 7714	Xu, Shan,Zhou, Yanping,Geng, Hui,et al. Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.[J]. SCIENTIFIC REPORTS,2017,7(1):17524.
APA	Xu, Shan.,Zhou, Yanping.,Geng, Hui.,Song, Dandan.,Tang, Jing.,...&Cui, Yanfang*.(2017).Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones..SCIENTIFIC REPORTS,7(1),17524.
MLA	Xu, Shan,et al."Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.".SCIENTIFIC REPORTS 7.1(2017):17524.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。